Reduction of gastro-intestinal adverse effect risk in long-term therapy with acetylsalicylic acid
Aim. To study the safety and tolerability of long-term anti-aggregant therapy in patients with coronary heart disease (CHD), comparing enteric-coated acetylsalicylic acid (ASA) and standard ASA forms. Material and methods. The study included 100 CHD patients, with myocardial infarction in anamnesis....
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2103 |